Scotiabank Adjusts Suncor Energy (SU) Price Target Upward, Maintains Sector Perform
On April 14, JPMorgan raised its price goal on SU to C$105 from C$79 and kept an Overweight rating as part of a Q1 preview.
Insider Monkey Blog
Bank of America Raises CNI Price Target to $122 on Strong Volume Momentum
On April 9, BofA upgraded Canadian National Railway Company (NYSE:CNI) to Buy from Neutral. It also raised its price target to $122 from $117.
Is Linde (LIN) One of the Best Dividend Aristocrat Stocks to Buy in 2026?
On April 21, Bank of America raised its price recommendation on Linde plc (NASDAQ:LIN) to $525 from $520. It maintained a Buy rating on the shares.
International Business Machines (IBM) – Among the 10 Best Dividend Aristocrat Stocks to Buy in 2026
On April 23, Morgan Stanley raised its price recommendation on International Business Machines Corporation (NYSE:IBM) to $225 from $215.
Roper (ROP) Ups Guidance, Announces $3B Buyback Expansion
On April 23, Reuters reported that Roper Technologies, Inc.
Guggenheim Lifts Target (TGT) PT, Sees Turnaround Gaining Traction
On April 20, John Heinbockel at Guggenheim Partners raised the price recommendation on Target Corporation (NYSE:TGT) to $140 from $130.
Wells Fargo Raises Chubb (CB) PT, Citizens Calls it a Top Pick
On April 23, Elyse Greenspan at Wells Fargo raised the price recommendation on Chubb Limited (NYSE:CB) to $333 from $321. It reiterated an Equal Weight rating on the shares.
Bank of America Cuts Pentair (PNR) PT to $88, Sees Weak Q1 Ahead
On April 20, Shaun Calnan at Bank of America lowered the price recommendation on Pentair plc (NYSE:PNR) to $88 from $100. It reiterated an Underperform rating on the shares.
Truist Lowers GPC Target to $124, Notes Margin Recovery
On April 22, Scot Ciccarelli at Truist Financial lowered the price recommendation on Genuine Parts Company (NYSE:GPC) to $124 from $127.
Piper Sandler Trims Becton Dickinson (BDX) PT on Model Revisions
On April 17, Jason Bednar at Piper Sandler lowered the price target on Becton, Dickinson and Company (NYSE:BDX) to $159 from $170 and kept a Neutral rating.
Bank of America Boosts APD Price Target, Sees Commodity Tailwinds Into 2026
On April 21, Bank of America raised its price recommendation on Air Products and Chemicals, Inc. (NYSE:APD) to $303 from $280.
Baird Trims Stanley Black & Decker (SWK) PT on Weak Channel Checks
On April 21, Timothy Wojs at Baird lowered the price recommendation on Stanley Black & Decker, Inc. (NYSE:SWK) to $82 from $85. It reiterated a Neutral rating on the shares.
Jim Cramer on Mega Fortune Company: “You Simply Have to Take Some Profits or Else”
Mega Fortune Company Limited (NASDAQ:MGRT) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer on Insulet Corporation: “It’s Still Too Expensive Because of the GLP-1 Threat”
Insulet Corporation (NASDAQ:PODD) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer on Rivian: “It Looks Like They’re Going to Make It”
Rivian Automotive, Inc. (NASDAQ:RIVN) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer on Dave Inc.: “We Are Going to Sell Fintech”
Dave Inc. (NASDAQ:DAVE) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer Says “We Cannot Be in SoundHound”
SoundHound AI, Inc. (NASDAQ:SOUN) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer Recommends MP Materials Over Critical Metals Corp.
Critical Metals Corp. (NASDAQ:CRML) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer Says “PG&E Is a Great Growth Story”
PG&E Corporation (NYSE:PCG) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer on Thermo Fisher: “I Think That the Market Has This Wrong”
Thermo Fisher Scientific Inc. (NYSE:TMO) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer Discusses the Recent Performance and Earnings Result of Dow Inc.
Dow Inc. (NYSE:DOW) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer on UnitedHealth: “The Stock Deserves to Be Much Higher”
UnitedHealth Group Incorporated (NYSE:UNH) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer Says Johnson & Johnson “Has the Best Pipeline of Potential Blockbusters”
Johnson & Johnson (NYSE:JNJ) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer Says Cardinal Health Is a “Steal”
Cardinal Health, Inc. (NYSE:CAH) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer on CVS Health: “I Think It’s Only Going to Get Better as the Competition Disappears”
CVS Health Corporation (NYSE:CVS) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer on Tesla: “I’m Not a Seller of the Future, I’m a Buyer of the Future”
Tesla, Inc. (NASDAQ:TSLA) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer on Meta: “I Think Mark Zuckerberg Is Being Efficient”
Meta Platforms, Inc. (NASDAQ:META) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer on ServiceNow: “The Market’s Changed, the Buyers Turned Into Sellers”
ServiceNow, Inc. (NYSE:NOW) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer Credits Lip-Bu Tan For an Amazing Performance of Intel
Intel Corporation (NASDAQ:INTC) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer on Home Depot: “This Is the Stock You Own When You Get Rate Cuts”
The Home Depot, Inc. (NYSE:HD) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer on Lightwave Logic: “Perfect Candidate For Selling Half Your Stock Tomorrow Morning”
Lightwave Logic, Inc. (NASDAQ:LWLG) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Jim Cramer on POET: “Sounds Interesting, But Not 100% Up Interesting, Sell Some”
POET Technologies Inc. (NASDAQ:POET) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
10 Best May Dividend Stocks to Buy
Investing in dividend stocks sounds straightforward, but it takes more work than it seems. A basic yield is only part of the picture.
5 Best May Dividend Stocks to Buy
On April 24, Guggenheim Partners raised its price recommendation on Sirius XM Holdings Inc. (NASDAQ:SIRI) to $34 from $29. It reiterated a Buy rating.
What Makes Maze Therapeutics (MAZE) One of the Best Oversold Small-Cap Stocks to Buy
As of the April 24 closing, the consensus sentiment around the stock was strongly bullish. It received Buy ratings from all 12 analysts who provided coverage.
Northland Reaffirms Outperform Rating for MiMedx Group (MDXG)
On April 17, Northland reduced the price target on MiMedx Group Inc. (NASDAQ:MDXG) from $10 to $6, which still results in an adjusted upside of more than 75%.
Truist Reiterates Buy Rating for Viridian Therapeutics (VRDN)
On April 21, Truist reduced the price target on Viridian Therapeutics Inc. (NASDAQ:VRDN) from $36 to $33 while maintaining a Buy rating on the stock.
Why Does Burford Capital (BUR) Appear so Attractive
On March 30, Wedbush downgraded Burford Capital Ltd. (NYSE:BUR) stock rating to Neutral from Outperform. The firm also cut down the target price from $6 to $4.75.
TAT Technologies (TATT) Positioned to Capitalize on Long-Term Secular Trends
On April 8th, B. Riley initiated its coverage of TAT Technologies Ltd. (NASDAQ:TATT), assigning a Buy rating with a $61 price target for the stock.
Mama’s Creations (MAMA) Fuels Confidence Following Q4 Outperformance
On April 16, DA Davidson increased the price target on Mama’s Creations Inc. (NASDAQ:MAMA) from $24 to $25, resulting in an adjusted upside of almost 73%.
Insteel Industries (IIIN) Sits Comfortably With Current Market Position, Following Q2 Announcement
On April 16, Insteel Industries Inc. (NYSE:IIIN) reported earnings per share of $0.27 for the second quarter, down from $0.52 per share last year.
BofA Reaffirms Buy Rating for Agios Pharmaceuticals (AGIO)
On April 21, BofA analyst Alec Stranahan reduced the price target on Agios Pharmaceuticals Inc. (NASDAQ:AGIO) to $41 from $44, while maintaining a Buy rating on the stock.
Here is Why Investors Should Pay Attention to IRADIMED Corp. (IRMD)
As of the April 24 closing, the stock carries a strongly bullish consensus sentiment. It received Buy ratings from all 3 analysts who covered the stock.
Ennis Inc. (EBF) Delivers In-Line Fourth Quarter Results
The company’s recent results announcement offers a lot of encouragement. On April 20, Ennis Inc.
What Makes Anavex Life Sciences (AVXL) One of the Best Shorted Penny Stocks
More than 500% upside potential as of the April 23 close supports a highly bullish stance on the stock.
Here is Why Altimmune Inc. (ALT) Appears to be an Attractive Penny Stock
On March 19, Truist began coverage of Altimmune Inc. (NASDAQ:ALT) with a $12 price target, leading to a whopping 315% upside potential at the prevailing level.
Richtech Robotics Inc. (RR) Scaling Abroad Through Strategic Collaboration
On April 8, Richtech Robotics Inc. (NASDAQ:RR) entered into a distribution agreement with the Netherlands-based consultancy firm NewConsultancy B.V.
EVgo Inc. (EVGO) is One of the Best Shorted Penny Stocks to Look at, Here is Why
On March 13, Morgan Stanley reduced the price target on EVgo Inc. (NASDAQ:EVGO) from $4.50 to $3.50, which still results in an upside potential of more than 60%.
ThredUp Inc. (TDUP) Garnering Attention with Mass-Market Resale Network Positioning
On April 6, Oliver Chen from TD Cowen assigned a Buy rating to ThredUp Inc. (NASDAQ:TDUP) and set a price target of $5.
Recursion Pharmaceuticals (RXRX) Offers Encouraging Prospects After Setting 2026 Priorities
The stock offers a 100% upside potential at the prevailing level, as of April 23 closing, based on its 1-year median price target of $7.
Hedge Fund Resource Center
